This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: Deterrence as a goal of incarceration refers to what outcome? a) Reducing the likelihood that ... (Read 18 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
on: Jun 22, 2018
Deterrence as a goal of incarceration refers to what outcome?
 
  a) Reducing the likelihood that others might engage in problematic behavior in the futur
  b) Removing the offender from the community for a predetermined length of time
  c) Offenders receiving substance abuse treatment as part of their incarceration
  d) Offenders receiving substance abuse treatment as part of their incarceration

Question 2

Which of these is an anabolic effect?
 
  a) Promoting protein growth and muscle developmen
  b) Promoting the development of male sex characteristics
  c) Promoting improved performance
  d) Promoting the reduction of inflammation


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

LVPMS

  • Sr. Member
  • ****
  • Posts: 323
Reply #1 on: Jun 22, 2018
Answer to Question 1

A

Answer to Question 2

A


crobinson2013

  • Member
  • Posts: 535
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it

phuda

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Great answer, keep it coming :)

« previous next »
 

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

EXAMPLES OF NURSING-SENSITIVE OUTCOME MEASURES EXAMPLES OF NURSING-SENSITIVE OUTCOME MEASURES
Tracking Goal-Setting Progress Tracking Goal-Setting Progress
Likelihood of Developing Type 2 Diabetes Mellitus Based on BMI Likelihood of Developing Type 2 Diabetes Mellitus Based on BMI
NADH acts as a reducing agent in several reactions NADH acts as a reducing agent in several reactions
Reducing Pesticides in Food Reducing Pesticides in Food
Which outcome corresponds to the reaction:H3AsO4 + 3 OH- → 3 H2O + AsO43-? Which outcome corresponds to the reaction:H3AsO4 + 3 OH- → 3 H2O + AsO43-?
Video: Transmission Across a Synapse

For a complete list of videos, visit our video library